Hasan Ökmen
Hasan Ökmen has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Fatih Dal
University of Health Sciences, Turkey
6 shared publications - Kıvılcım Ulusan
Department of General Surgery, Health Sciences University Turkish Ministry of Health İstanbul Research and Training Hospital, İstanbul, Turkey
5 shared publications - Semiha Battal Havare
Department of Pathology, University of Health Sciences Turkey, Istanbul Training and Research Hospital, 34098 Istanbul, Turkey
4 shared publications - Serkan Sari
Department of General Surgery, Division of Endocrine Surgery, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey
4 shared publications - Ekrem Ferlengez
Department of General Surgery, Istanbul Oncology Hospital, 34846 Istanbul, Turkiye
3 shared publications - Şükrü Çolak
Department of General Surgery, Health Sciences University Turkish Ministry of Health İstanbul Research and Training Hospital, İstanbul, Turkey
3 shared publications
Latest Publications
- 1 August 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (3) , 279-285
Results of 78 Patients with Idiopathic Granulomatous Mastitis Who Received Peroral Steroid Therapy: Our Clinical Experience
- 1 August 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (3) , 279-285
Results of 78 Patients with Idiopathic Granulomatous Mastitis Who Received Peroral Steroid Therapy: Our Clinical Experience
- 1 August 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (3) , 312-315
Comparison of Spinal Anesthesia vs. Local Infiltration Anesthesia in Postoperative Pain in Patients Undergoing Sinusectomy Surgery
- 1 August 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (3) , 312-315
Comparison of Spinal Anesthesia vs. Local Infiltration Anesthesia in Postoperative Pain in Patients Undergoing Sinusectomy Surgery
- 31 May 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (2) , 139-143
Does Pain Following Laparoscopic Cholecystectomy Differ in Diabetics?
- 31 May 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (2) , 139-143
Does Pain Following Laparoscopic Cholecystectomy Differ in Diabetics?
- 31 May 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (2) , 130-138
Bilateral Idiopathic Granulomatous Mastitis: Outcomes of a Tertiary Hospital
- 31 May 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (2) , 130-138
Bilateral Idiopathic Granulomatous Mastitis: Outcomes of a Tertiary Hospital
- 1 February 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (1) , 32-35
Evaluation of Subclavian Central Venous Port Catheters Placed by Anesthesiologists: Single-Center Experience
- 1 February 2023
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 24 (1) , 32-35
Evaluation of Subclavian Central Venous Port Catheters Placed by Anesthesiologists: Single-Center Experience
- Open Access
- 1 January 2023
- Published by Kare Publishing in Turkish Journal of Trauma and Emergency Surgery
- Vol. 29 (9) , 1026-1031
Is diagnostic laparoscopy necessary in the management of left thoracoabdominal stab wounds?
The diagnosis of a diaphragmatic rupture and the identification of patients for surgical repair is challenging despite current diagnostic algorithms and imaging technologies. Unless treated on time, acute traumatic diaphragmatic injury due to stab wounds has a high mortality and morbidity rate, with an increasing trend in the presence of organ herniation. In this study, we aimed to investigate the efficacy of diagnostic laparoscopy in patients with an anterior thoracoabdominal stab wound and to compare the follow-up outcomes of cases. We retrospectively reviewed our institutional database of patients who were admitted with stab wounds between October 2012 and 2022. Patients who underwent diagnostic laparoscopy were divided into two groups depending on the presence of a diaphragmatic injury. We analyzed demographics, the success of computed tomography (CT) imaging in the diagnosis, the presence of hemomediastinum, pneumomediastinum, tube thoracostomy application, associated organ injury, type of surgery, duration of surgery, complications, and the length of stay between the groups. Of the 39 patients with penetrating left thoracoabdominal injury underwent diagnostic laparoscopy, CT had a diagnostic sensitivity of 63.16% (95% Confidence interval [CI] 38.36–83.71%), and a specificity of 100% (95% CI 82.35–100.00%). We could not find a statistically significant difference between the groups in terms of studied variables, while operation time was significantly higher in the diaphragmatic injury group (P<0.01). Fourteen patients had accompanied visceral injuries. Diagnostic laparoscopy is still the gold standard particularly in the ER setting, particularly in the absence of an experienced radiologist for 24 h and when the close monitoring of the patient by the same team cannot be provided.
- 1 January 2023
- Published by Kare Publishing in Turkish Journal of Trauma and Emergency Surgery
- Vol. 29 (9) , 1026-1031
Open AccessIs diagnostic laparoscopy necessary in the management of left thoracoabdominal stab wounds?
The diagnosis of a diaphragmatic rupture and the identification of patients for surgical repair is challenging despite current diagnostic algorithms and imaging technologies. Unless treated on time, acute traumatic diaphragmatic injury due to stab wounds has a high mortality and morbidity rate, with an increasing trend in the presence of organ herniation. In this study, we aimed to investigate the efficacy of diagnostic laparoscopy in patients with an anterior thoracoabdominal stab wound and to compare the follow-up outcomes of cases. We retrospectively reviewed our institutional database of patients who were admitted with stab wounds between October 2012 and 2022. Patients who underwent diagnostic laparoscopy were divided into two groups depending on the presence of a diaphragmatic injury. We analyzed demographics, the success of computed tomography (CT) imaging in the diagnosis, the presence of hemomediastinum, pneumomediastinum, tube thoracostomy application, associated organ injury, type of surgery, duration of surgery, complications, and the length of stay between the groups. Of the 39 patients with penetrating left thoracoabdominal injury underwent diagnostic laparoscopy, CT had a diagnostic sensitivity of 63.16% (95% Confidence interval [CI] 38.36–83.71%), and a specificity of 100% (95% CI 82.35–100.00%). We could not find a statistically significant difference between the groups in terms of studied variables, while operation time was significantly higher in the diaphragmatic injury group (P<0.01). Fourteen patients had accompanied visceral injuries. Diagnostic laparoscopy is still the gold standard particularly in the ER setting, particularly in the absence of an experienced radiologist for 24 h and when the close monitoring of the patient by the same team cannot be provided.
- 14 July 2022
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 85 (3) , 522-530
Diagnostic Conflict in Occult Breast Cancers and Clinical Results of a Tertiary Center: A Cross-sectional Study
- 14 July 2022
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 85 (3) , 522-530
Diagnostic Conflict in Occult Breast Cancers and Clinical Results of a Tertiary Center: A Cross-sectional Study
- Open Access
- 1 March 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (3) , 405-412
Does focal heterogeneity affect survival in postoperative ipsilateral multifocal and multicentric breast cancers?
OBJECTIVE: In multicentric/multifocal breast tumors, there may be immunological and histological differences between foci that may affect survival and treatment choice. We aimed to evaluate the effect of focal heterogeneity seen in multicentric/multifocal breast tumors on survival. METHODS: We retrospectively collected and analyzed the clinicopathological data of 89 female patients with multifocal/multicentric breast cancer, whose surgical and medical treatment was completed and who were followed up for 5 years. RESULTS: Of all patients, 29.2% (26/89) were heterogeneous. Heterogeneity of these foci was as follows: histologic heterogeneity of index foci (mix type): 15.7% (14/89), histologic heterogeneity of inter-foci: 7.9% (7/89), and immunohistochemical heterogeneity of inter-foci: 10.1% (9/89). When additional foci were evaluated, oncological therapy was changed for 3 (3.3%) of 89 patients. Heterogeneity does not have a significant (p>0.05) effect on recurrence and survival in multicentric/multifocal breast cancers. Pathological N stage is an independent risk factor for disease-free survival (hazard ratio=2.29, 95% confidence interval=1.39-3.76, p=0.001). CONCLUSIONS: In multifocal/multicentric breast cancers, less than 4% of patients may experience heterogeneity requiring change in the therapeutic decision. However, heterogeneity does not have a significant effect on recurrence and survival in multifocal/multicentric breast cancers. The pathological N stage is an independent risk factor for disease-free survival.
- 1 March 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (3) , 405-412
Open AccessDoes focal heterogeneity affect survival in postoperative ipsilateral multifocal and multicentric breast cancers?
OBJECTIVE: In multicentric/multifocal breast tumors, there may be immunological and histological differences between foci that may affect survival and treatment choice. We aimed to evaluate the effect of focal heterogeneity seen in multicentric/multifocal breast tumors on survival. METHODS: We retrospectively collected and analyzed the clinicopathological data of 89 female patients with multifocal/multicentric breast cancer, whose surgical and medical treatment was completed and who were followed up for 5 years. RESULTS: Of all patients, 29.2% (26/89) were heterogeneous. Heterogeneity of these foci was as follows: histologic heterogeneity of index foci (mix type): 15.7% (14/89), histologic heterogeneity of inter-foci: 7.9% (7/89), and immunohistochemical heterogeneity of inter-foci: 10.1% (9/89). When additional foci were evaluated, oncological therapy was changed for 3 (3.3%) of 89 patients. Heterogeneity does not have a significant (p>0.05) effect on recurrence and survival in multicentric/multifocal breast cancers. Pathological N stage is an independent risk factor for disease-free survival (hazard ratio=2.29, 95% confidence interval=1.39-3.76, p=0.001). CONCLUSIONS: In multifocal/multicentric breast cancers, less than 4% of patients may experience heterogeneity requiring change in the therapeutic decision. However, heterogeneity does not have a significant effect on recurrence and survival in multifocal/multicentric breast cancers. The pathological N stage is an independent risk factor for disease-free survival.
- 24 January 2022
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 84 (6) , 1231-1238
Prognostic Factors Effective on Survival in Unifocal Borderline Luminal B HER2-Negative and Triple-Negative Breast Cancers: a Cross-Sectional Study
- 24 January 2022
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 84 (6) , 1231-1238
Prognostic Factors Effective on Survival in Unifocal Borderline Luminal B HER2-Negative and Triple-Negative Breast Cancers: a Cross-Sectional Study
- Open Access
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (1) , 94-99
Hemogram index parameters in the evaluation of male breast cancer and inflammatory response: a case-control study
Our aim was to investigate the hemogram index parameters and their clinical significance in the evaluation of the inflammatory response of patients with male breast cancer, who are rarely observed in the literature. In total, 22 (n=22) healthy male and 28 (n=28) male breast cancer patients without synchronous/metachronous tumors were included in this study. They were grouped as the healthy male control group (Group 1) and the male breast cancer patient group (Group 2). The male breast cancer was divided into two subgroups, namely, early stage [(stage: 0/I/II) (Group 2A)] and late stage [(stage: III/IV) (Group 2B)], and their hemogram index parameters were compared. A significant (p>0.05) increase was observed in neutrophil/lymphocyte ratio (NLR) and·platelet/lymphocyte ratio (PLR) values in the late stage (Group 2B: stage III/IV) compared to the early stage (Group 2A: stage 0/I/II) and healthy control (Group 1) groups. In male breast cancer patients, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio values were significantly higher as the stage of cancer increased. These readily available simple tests can be used to evaluate the host's inflammatory response in male breast cancer.
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 68 (1) , 94-99
Open AccessHemogram index parameters in the evaluation of male breast cancer and inflammatory response: a case-control study
Our aim was to investigate the hemogram index parameters and their clinical significance in the evaluation of the inflammatory response of patients with male breast cancer, who are rarely observed in the literature. In total, 22 (n=22) healthy male and 28 (n=28) male breast cancer patients without synchronous/metachronous tumors were included in this study. They were grouped as the healthy male control group (Group 1) and the male breast cancer patient group (Group 2). The male breast cancer was divided into two subgroups, namely, early stage [(stage: 0/I/II) (Group 2A)] and late stage [(stage: III/IV) (Group 2B)], and their hemogram index parameters were compared. A significant (p>0.05) increase was observed in neutrophil/lymphocyte ratio (NLR) and·platelet/lymphocyte ratio (PLR) values in the late stage (Group 2B: stage III/IV) compared to the early stage (Group 2A: stage 0/I/II) and healthy control (Group 1) groups. In male breast cancer patients, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio values were significantly higher as the stage of cancer increased. These readily available simple tests can be used to evaluate the host's inflammatory response in male breast cancer.